Naheed Kurji logo

Naheed Kurji

North America, Ontario, Canada, Toronto

Description

Naheed Kurji is the President and CEO of Cyclica, a Toronto-based biotechnology company that leverages artificial intelligence and computati...

Investor Profile

Naheed Kurji has backed more than 2 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Seed rounds (top funding stages).
  • Majority of deals are located in Canada, United Kingdom.
  • Strong thematic focus on Biotechnology, Health Care, Medical.

Stage Focus

  • Series B (50%)
  • Seed (50%)

Country Focus

  • Canada (50%)
  • United Kingdom (50%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Artificial Intelligence (Ai)
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Naheed Kurji frequently co-invest with?

Drive Capital
North America, Ohio, United States, Columbus
Co-Investments: 1
GreenSky Ventures
North America, Ontario, Canada, Toronto
Co-Investments: 1
Continuum Health Ventures
North America, Ontario, Canada, Toronto
Co-Investments: 1
LS
Europe, England, United Kingdom, London
Co-Investments: 1
Chiesi Farmaceutici
Europe, Emilia-Romagna, Italy, Parma
Co-Investments: 1
Montage Ventures
North America, California, United States, Menlo Park
Co-Investments: 1
APEX Ventures
Europe, Wien, Austria, Vienna
Co-Investments: 1

What are some of recent deals done by Naheed Kurji?

CardiaTec Biosciences

Cambridge, Cambridgeshire, United Kingdom

CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery.

Artificial Intelligence (AI)BiotechnologyLife Science
SeedSep 10, 2024
Amount Raised: $6,500,000
Cyclica

Toronto, Ontario, Canada

Cyclica is a company that creates patented cloud-based predictive analytics software to find safer and more effective medicines.

BiotechnologyHealth CareMedicalPharmaceutical
Series BJun 24, 2020
Amount Raised: $16,855,065